Ola Winqvist
Chief Executive Officer bei ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL)
Profil
Ola Winqvist was the founder of SentoClone AB, established in 2004, where he served as Director from 2009 to 2012.
He is also the founder of ISR Immune System Regulation Holding AB, founded in 2015, where he currently holds the position of Chief Executive Officer.
In addition to his founding positions, Dr. Winqvist currently holds several other roles.
He is the Chairman of Svenska Läkaresällskapet, ImmunoWise AB, TLA Targeted Immunotherapies AB, and a Professor at Karolinska Institutet.
Previously, Dr. Winqvist worked as a Director at Goodwill Industries of North Louisiana, Inc. Dr. Winqvist obtained a doctorate degree from the University of Uppsala.
Aktive Positionen von Ola Winqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| ISR IMMUNE SYSTEM REGULATION HOLDING AB (PUBL) | Chief Executive Officer | 01.01.2018 |
| Karolinska Institutet | Corporate Officer/Principal | - |
TLA Targeted Immunotherapies AB
 TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Director/Board Member | - |
| ImmunoWise AB | Chairman | - |
| Svenska Läkaresällskapet | Chairman | - |
Ehemalige bekannte Positionen von Ola Winqvist
| Unternehmen | Position | Ende |
|---|---|---|
SentoClone AB
 SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Founder | 31.12.2012 |
Goodwill Industries of North Louisiana, Inc.
 Goodwill Industries of North Louisiana, Inc. Services to the Health IndustryHealth Services Goodwill Industries of North Louisiana, Inc. provides vocational programs and employment services for people with disabilities and in disadvantaged conditions. It offers multiple job resource centers, equipped with job-search experts, computers, Internet access and telephones. The firm also offers programs and contract services. The company was founded in 1926 and is headquartered in Shreveport, LA. | Director/Board Member | - |
Ausbildung von Ola Winqvist
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
SentoClone AB
SentoClone AB Miscellaneous Commercial ServicesCommercial Services SentoClone AB is a Swedish scientific research company developing SentoClone® - a patented method where the immune defense system is activated and strengthened to combat cancer. SentoClone is registered with the European Medicines Ageny, EMEA, as an SME (small and medium sized enterprises). SentoClone AB is a member of the IML, The Swedish Association for small and medium-sized companies active in R&D. SentoClone AB is owned by a number of venture capital firms, among them Stena Adactum AB, Sahltech i Göteborg AB and T-bolaget AB, together with founders Ola Winqvist and Magnus Thörn. | Commercial Services |
Goodwill Industries of North Louisiana, Inc.
Goodwill Industries of North Louisiana, Inc. Services to the Health IndustryHealth Services Goodwill Industries of North Louisiana, Inc. provides vocational programs and employment services for people with disabilities and in disadvantaged conditions. It offers multiple job resource centers, equipped with job-search experts, computers, Internet access and telephones. The firm also offers programs and contract services. The company was founded in 1926 and is headquartered in Shreveport, LA. | Health Services |
TLA Targeted Immunotherapies AB
TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Electronic Technology |
ISR Immune System Regulation Holding AB
 ISR Immune System Regulation Holding AB Pharmaceuticals: MajorHealth Technology ISR Immune System Regulation Holding AB engages in pharmaceutical research for the treatment of viral diseases focusing on Human Immunodeficiency Virus (HIV). It is developing ISR048 for the novel treatment of HIV. The company was founded by Yen Lundgren and Ulf Ljungblad in September 17, 2015 and is headquartered in Solna, Sweden. | Health Technology |
| Svenska Läkaresällskapet | |
| ImmunoWise AB |
